SUCHART THREETHIPTHIKOON, M.D.
Psychiatry
This website uses cookies 🍪
We use cookies to ensure you get the best online experience. For more details, please see our Privacy and Cookie Policy. Read more.
Psychiatrist's Recommendation: Stress vs. COVID-19
By Dr. Suchart Treethipthikun, Psychiatrist
Since late 2019, COVID-19 has emerged as a global pandemic, claiming the lives of over 3.71 million people worldwide out of approximately 173 million confirmed cases. In Thailand alone, as of June 7, 2021, there have been 1,213 deaths from 175,000 confirmed cases.
In the early months of 2020, when the outbreak began to significantly affect the daily lives of many Thai citizens, hope was placed on the development of a COVID-19 vaccine, with the public eager to receive it as soon as possible.
Eventually, the first COVID-19 vaccine—produced by Pfizer—was administered to Margaret Keenan, a 90-year-old British woman. Subsequently, vaccine distribution expanded across various countries.
However, reports of severe allergic reactions and even deaths following vaccination led to growing doubts, fears, and public resistance to receiving the vaccine. Such sentiments were seen in countries like Hong Kong, Taiwan, South Korea, Japan, the United States, and Thailand. This prompted governments to implement various strategies to encourage public participation in the vaccination program.
Currently, widespread anxiety exists among the Thai population, which can be categorized into three groups:
These individuals have continuously called on the government to acquire a wide variety of vaccines in sufficient quantities and distribute them promptly.
This group harbors significant concern about potential allergic reactions to the vaccine, including fears of paralysis or death. Such anxieties have been fueled by media reports lacking clear explanations from relevant authorities.
These individuals are open to vaccination but prefer to select a specific brand or type of vaccine.
Many medical experts have provided insights on YouTube regarding whether one should receive the vaccine. I encourage readers to explore these resources for further information:
As a psychiatrist, I offer the following guidance:
Psychiatric patients experiencing acute symptoms should be stabilized before vaccination. These include individuals with:
Certain psychiatric medications—especially antidepressants such as amitriptyline or SSRIs (e.g., fluoxetine, sertraline)—may require temporary adjustment. It is advisable to pause these medications one day before and one day after receiving the vaccine (a total of two days), under the supervision of a physician.
For those uncertain about their condition or medication, individual consultation with a physician is essential.
Some individuals may experience a specific set of symptoms before or after receiving the COVID-19 vaccine, including:
This condition is known medically as vasovagal syncope, commonly referred to as fainting. It often arises from acute stress, such as fear of needles or hearing nearby conversations about severe allergic reactions. This triggers an intense parasympathetic nervous system response, leading to slowed heart rate, widespread vasodilation, and a sudden drop in blood flow to the brain and limbs—resulting in fainting.
Symptoms typically last only a few seconds to a maximum of two minutes. Recovery is spontaneous, and further care is administered by healthcare personnel on site.
Even after vaccination, continued adherence to preventive measures—such as wearing masks, maintaining social distance, and regular handwashing—is crucial for long-term protection.
June 22, 2021
Psychiatry